[ASAP] From Hit to Lead: Structure-Based Optimization of Novel Selective Inhibitors of Receptor-Interacting Protein Kinase 1 (RIPK1) for the Treatment of Inflammatory Diseases

TOC Graphic

Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.3c02102

Source link

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts